Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Neuropathologica
Published in: Acta Neuropathologica 6/2014

Open Access 01-12-2014 | Original Paper

Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis

Authors: Manja Schubert, Debabrata Panja, Mette Haugen, Clive R. Bramham, Christian A. Vedeler

Published in: Acta Neuropathologica | Issue 6/2014

Login to get access

Abstract

Paraneoplastic cerebellar degeneration (PCD) is characterized by loss of Purkinje cells (PCs) associated with progressive pancerebellar dysfunction in the presence of onconeural Yo antibodies. These antibodies recognize the cerebellar degeneration-related antigens CDR2 and CDR2L. Response to PCD therapy is disappointing due to limited understanding of the neuropathological mechanisms. Here, we report the pathological role of CDR antibodies on the calcium homeostasis in PCs. We developed an antibody-mediated PCD model based on co-incubation of cerebellar organotypic slice culture with human patient serum or rabbit CDR2 and CDR2L antibodies. The CDR antibody-induced pathology was investigated by high-resolution multiphoton imaging and biochemical analysis. Both human and rabbit CDR antibodies were rapidly internalized by PCs and led to reduced immunoreactivity of calbindin D28K (CB) and L7/Pcp-2 as well as reduced dendritic arborizations in the remaining PCs. Washout of the CDR antibodies partially recovered CB immunoreactivity, suggesting a transient structural change in CB calcium-binding site. We discovered that CDR2 and CB co-immunoprecipitate. Furthermore, the expression levels of voltage-gated calcium channel Cav2.1, protein kinase C gamma and calcium-dependent protease, calpain-2, were increased after CDR antibody internalization. Inhibition of these signaling pathways prevented or attenuated CDR antibody-induced CB and L7/Pcp-2 immunoreactivity loss, morphological changes and increased protein expression. These results signify that CDR antibody internalization causes dysregulation of cell calcium homeostasis. Hence, drugs that modulate these events may represent novel neuroprotective therapies that limit the damaging effects of CDR antibodies and prevent PC neurodegeneration.
Appendix
Available only for authorised users
Literature
1.
Airaksinen MS, Eilers J, Garaschuk O, Thoenen H, Konnerth A, Meyer M (1997) Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene. Proc Natl Acad Sci USA 94(4):1488–1493PubMedCentralPubMedCrossRef
2.
Albert ML, Austin LM, Darnell RB (2000) Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol 47(1):9–17PubMedCrossRef
3.
Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB (1998) Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 4(11):1321–1324PubMedCrossRef
4.
Barski JJ, Hartmann J, Rose CR, Hoebeek F, Mörl K, Noll-Hussong M, De Zeeuw CI, Konnerth A, Meyer M (2003) Calbindin in cerebellar Purkinje cells is a critical determinant of the precision of motor coordination. J Neurosci 23(8):3469–3477PubMed
5.
6.
7.
De Beukelaar JW, Sillevis Smitt PA (2006) Managing paraneoplastic neurological disorders. Oncologist 11(3):292–305PubMedCrossRef
8.
Bright R, Mochly-Rosen D (2005) The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke J Cereb Circ 36(12):2781–2790CrossRef
9.
Buki A, Farkas O, Doczi T, Povlishock JT (2003) Preinjury administration of the calpain inhibitor MDL-28170 attenuates traumatically induced axonal injury. J Neurotrauma 20(3):261–268PubMedCrossRef
10.
Carpenter EL, Vance BA, Klein RS, Voloschin A, Dalmau J, Vonderheide RH (2008) Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration. J Neuroimmunol 193(1–2):173–182PubMedCrossRef
11.
Cedervall T, Berggård T, Borek V, Thulin E, Linse S, Åkerfeldt KS (2005) Redox sensitive cysteine residues in calbindin D 28k are structurally and functionally important. Biochemistry (Mosc) 44(2):684–693CrossRef
12.
Cheung ECC, Slack RS (2004) Emerging role for ERK as a key regulator of neuronal apoptosis. Sci STKE Signal Transduct Knowl Environ 251:PE45
13.
Cho S, Wood A, Bowlby MR (2007) Brain slices as models for neurodegenerative disease and screening platforms to identify novel therapeutics. Curr Neuropharmacol 5(1):19–33PubMedCentralPubMedCrossRef
14.
Congdon EE, Gu J, Sait HBR, Sigurdsson EM (2013) Antibody uptake into neurons occurs primarily via clathrin-dependent Fc receptor endocytosis and is a prerequisite for acute tau protein clearance. J Biol Chem 288(49):35452–35465PubMedCrossRef
15.
Corradi JP, Yang C, Darnell JC, Dalmau J, Darnell RB (1997) A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues. J Neurosci 17(4):1406–1415PubMed
16.
Crocker SJ, Smith PD, Jackson-Lewis V et al (2003) Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson’s disease. J Neurosci 23(10):4081–4091PubMed
17.
Czogalla A, Sikorski AF (2005) Spectrin and calpain: a “target” and a “sniper” in the pathology of neuronal cells. Cell Mol Life Sci 62(17):1913–1924PubMedCrossRef
18.
Dahm L, Ott C, Steiner J et al (2014) Seroprevalence of autoantibodies against brain antigens in health and disease: brain-targeting autoantibodies. Ann Neurol 76(1):82–94PubMedCrossRef
19.
20.
21.
Dupont J-L, Fourcaudot E, Beekenkamp H, Poulain B, Bossu J-L (2006) Synaptic organization of the mouse cerebellar cortex in organotypic slice cultures. Cerebellum Lond Engl 5(4):243–256CrossRef
22.
Eichler TW, Totland C, Haugen M, Qvale TH, Mazengia K, Storstein A, Haukanes BI, Vedeler CA (2013) CDR2L antibodies: a new player in paraneoplastic cerebellar degeneration. PLoS One 8(6):e66002PubMedCentralPubMedCrossRef
23.
Endo S, Launey T (2003) ERKs regulate PKC-dependent synaptic depression and declustering of glutamate receptors in cerebellar Purkinje cells. Neuropharmacology 45(6):863–872PubMedCrossRef
24.
25.
Fujishima K, Horie R, Mochizuki A, Kengaku M (2012) Principles of branch dynamics governing shape characteristics of cerebellar Purkinje cell dendrites. Development 139(18):3442–3455PubMedCentralPubMedCrossRef
26.
Gafni J, Ellerby LM (2002) Calpain activation in Huntington’s disease. J Neurosci 22(12):4842–4849PubMed
27.
Gao Z, Todorov B, Barrett CF, van Dorp S, Ferrari MD, van den Maagdenberg AMJM, De Zeeuw CI, Hoebeek FE (2012) Cerebellar ataxia by enhanced Ca(V)2.1 currents is alleviated by Ca2+-dependent K+-channel activators in Cacna1a(S218L) mutant mice. J Neurosci 32(44):15533–15546PubMedCrossRef
28.
Ghoumari AM, Dusart I, El-Etr M, Tronche F, Sotelo C, Schumacher M, Baulieu E-E (2003) Mifepristone (RU486) protects Purkinje cells from cell death in organotypic slice cultures of postnatal rat and mouse cerebellum. Proc Natl Acad Sci 100(13):7953–7958PubMedCentralPubMedCrossRef
29.
Giorgi C, Agnoletto C, Baldini C et al (2010) Redox control of protein kinase C: cell- and disease-specific aspects. Antioxid Redox Signal 13(7):1051–1085PubMedCrossRef
30.
Greenlee JE (2006) Anti-Yo autoimmunity; dangerous for the brain but not the tumor? J Neurol Sci 250(1–2):1–2PubMed
31.
Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG (2010) Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. J Neuropathol Exp Neurol 69(10):997–1007PubMedCentralPubMedCrossRef
32.
Hartmann J, Konnerth A (2005) Determinants of postsynaptic Ca2+ signaling in Purkinje neurons. Cell Calcium 37(5):459–466PubMedCrossRef
33.
Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE (2009) Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflammation 6:31PubMedCentralPubMedCrossRef
34.
Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609–642PubMedCrossRef
35.
Junttila MR, Li S-P, Westermarck J (2008) Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J Off Publ Fed Am Soc Exp Biol 22(4):954–965
36.
Kawamura M, Nakajima W, Ishida A, Ohmura A, Miura S, Takada G (2005) Calpain inhibitor MDL 28170 protects hypoxic-ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis. Brain Res 1037(1–2):59–69PubMedCrossRef
37.
Kim JH (2005) Overexpression of calbindin-D28K in hippocampal progenitor cells increases neuronal differentiation and neurite outgrowth. FASEB J. doi:10.​1096/​fj.​05-4826fje
38.
Kim BJ, Lee SY, Kim HW, Park E-J, Kim J, Kim SJ, So I, Jeon J-H (2009) Optimized immunohistochemical analysis of cerebellar purkinje cells using a specific biomarker, calbindin D28k. Korean J Physiol Pharmacol 13(5):373PubMedCentralPubMedCrossRef
39.
Kinoshita-Kawada M, Oberdick J, Xi Zhu M (2004) A Purkinje cell specific GoLoco domain protein, L7/Pcp-2, modulates receptor-mediated inhibition of Cav2.1 Ca2+ channels in a dose-dependent manner. Brain Res Mol Brain Res 132(1):73–86PubMedCrossRef
40.
Kordasiewicz HB, Gomez CM (2007) Molecular pathogenesis of spinocerebellar ataxia type 6. Neurother J Am Soc Exp Neurother 4(2):285–294CrossRef
41.
42.
Ling C, Verbny YI, Banks MI, Sandor M, Fabry Z (2008) In situ activation of antigen-specific CD8+ T cells in the presence of antigen in organotypic brain slices. J Immunol 180(12):8393–8399PubMedCentralPubMedCrossRef
43.
Lonchamp E, Dupont J-L, Beekenkamp H, Poulain B, Bossu J-L (2006) The mouse cerebellar cortex in organotypic slice cultures: an in vitro model to analyze the consequences of mutations and pathologies on neuronal survival, development, and function. Crit Rev Neurobiol 18(1–2):179–186PubMedCrossRef
44.
Lossi L, Alasia S, Salio C, Merighi A (2009) Cell death and proliferation in acute slices and organotypic cultures of mammalian CNS. Prog Neurobiol 88(4):221–245PubMedCrossRef
45.
Metzger F, Kapfhammer JP (2000) Protein kinase C activity modulates dendritic differentiation of rat Purkinje cells in cerebellar slice cultures. Eur J Neurosci 12(6):1993–2005PubMedCrossRef
46.
Metzger F, Kapfhammer JP (2003) Protein kinase C: its role in activity-dependent Purkinje cell dendritic development and plasticity. Cerebellum Lond Engl 2(3):206–214CrossRef
47.
48.
O’Donovan KJ, Diedler J, Couture GC, Fak JJ, Darnell RB (2010) The onconeural antigen cdr2 is a novel APC/C target that acts in mitosis to regulate c-myc target genes in mammalian tumor cells. PLoS One 5(4):e10045PubMedCentralPubMedCrossRef
49.
Okano HJ, Park WY, Corradi JP, Darnell RB (1999) The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev 13(16):2087–2097PubMedCentralPubMedCrossRef
50.
Peden AH, Ironside JW (2012) Molecular pathology in neurodegenerative diseases. Curr Drug Targets 13(12):1548–1559PubMedCrossRef
51.
Roberts WK, Darnell RB (2004) Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol 16(5):616–622PubMedCrossRef
52.
Rodriguez M, Truh LI, O’Neill BP, Lennon VA (1988) Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells. Neurology 38(9):1380–1386PubMedCrossRef
53.
Saito K, Elce JS, Hamos JE, Nixon RA (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90(7):2628–2632PubMedCentralPubMedCrossRef
54.
Sakai K, Kitagawa Y, Saiki S, Saiki M, Hirose G (2004) Effect of a paraneoplastic cerebellar degeneration-associated neural protein on B-myb promoter activity. Neurobiol Dis 15(3):529–533PubMedCrossRef
55.
Sakai K, Shirakawa T, Li Y, Kitagawa Y, Hirose G (2002) Interaction of a paraneoplastic cerebellar degeneration-associated neuronal protein with the nuclear helix-loop-helix leucine zipper protein MRG X. Mol Cell Neurosci 19(4):477–484PubMedCrossRef
56.
Santomasso BD, Roberts WK, Thomas A, Williams T, Blachère NE, Dudley ME, Houghton AN, Posner JB, Darnell RB (2007) A T-cell receptor associated with naturally occurring human tumor immunity. Proc Natl Acad Sci USA 104(48):19073–19078PubMedCentralPubMedCrossRef
57.
Schwaller B (2012) The use of transgenic mouse models to reveal the functions of Ca2+ buffer proteins in excitable cells. Biochim Biophys Acta 1820(8):1294–1303PubMedCrossRef
58.
Seki T, Abe-Seki N, Kikawada T, Takahashi H, Yamamoto K, Adachi N, Tanaka S, Hide I, Saito N, Sakai N (2010) Effect of trehalose on the properties of mutant {gamma}PKC, which causes spinocerebellar ataxia type 14, in neuronal cell lines and cultured Purkinje cells. J Biol Chem 285(43):33252–33264PubMedCentralPubMedCrossRef
59.
Stabach PR, Cianci CD, Glantz SB, Zhang Z, Morrow JS (1997) Site-directed mutagenesis of alpha II spectrin at codon 1175 modulates its mu-calpain susceptibility. Biochemistry (Mosc) 36(1):57–65CrossRef
60.
61.
Storstein A, Krossnes BK, Vedeler CA (2009) Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies. Acta Neurol Scand 120(1):64–67PubMedCrossRef
62.
Storstein A, Monstad SE, Honnorat J, Vedeler CA (2004) Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum. J Neuroimmunol 155(1–2):150–154PubMedCrossRef
63.
Storstein A, Vedeler CA (2007) Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects. Adv Clin Chem 44:143–185PubMedCrossRef
64.
Sulaiman P, Fina M, Feddersen R, Vardi N (2010) Ret-PCP2 colocalizes with protein kinase C in a subset of primate ON cone bipolar cells. J Comp Neurol 518(7):1098–1112PubMedCentralPubMedCrossRef
65.
Sutton IJ, Steele J, Savage CO, Winer JB, Young LS (2004) An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies. J Neuroimmunol 150(1–2):98–106PubMedCrossRef
66.
Takanaga H, Mukai H, Shibata H, Toshimori M, Ono Y (1998) PKN interacts with a paraneoplastic cerebellar degeneration-associated antigen, which is a potential transcription factor. Exp Cell Res 241(2):363–372PubMedCrossRef
67.
68.
Tanaka K, Augustine GJ (2008) A positive feedback signal transduction loop determines timing of cerebellar long-term depression. Neuron 59(4):608–620PubMedCentralPubMedCrossRef
69.
Todorov B, Kros L, Shyti R et al (2012) Purkinje cell-specific ablation of Cav2.1 channels is sufficient to cause cerebellar ataxia in mice. Cerebellum Lond Engl 11(1):246–258CrossRef
70.
Totland C, Aarskog NK, Eichler TW, Haugen M, Nøstbakken JK, Monstad SE, Salvesen HB, Mørk S, Haukanes BI, Vedeler CA (2011) CDR2 antigen and Yo antibodies. Cancer Immunol Immunother CII 60(2):283–289CrossRef
71.
Totland C, Ying M, Haugen M, Mazengia K, Storstein A, Aarseth J, Martinez A, Vedeler C (2013) Avidity of onconeural antibodies is of clinical relevance. Cancer Immunol Immunother CII 62(8):1393–1396CrossRef
72.
73.
Wang JQ, Arora A, Yang L, Parelkar NK, Zhang G, Liu X, Choe ES, Mao L (2005) Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity. Mol Neurobiol 32(3):237–249PubMedCrossRef
74.
Wernyj RP, Mattson MP, Christakos S (1999) Expression of calbindin-D28k in C6 glial cells stabilizes intracellular calcium levels and protects against apoptosis induced by calcium ionophore and amyloid beta-peptide. Brain Res Mol Brain Res 64(1):69–79PubMedCrossRef
75.
Zadran S, Bi X, Baudry M (2010) Regulation of calpain-2 in neurons: implications for synaptic plasticity. Mol Neurobiol 42(2):143–150PubMedCrossRef
Metadata
Title
Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis
Authors
Manja Schubert
Debabrata Panja
Mette Haugen
Clive R. Bramham
Christian A. Vedeler
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Acta Neuropathologica / Issue 6/2014
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-014-1351-6

Other articles of this Issue 6/2014

Acta Neuropathologica 6/2014 Go to the issue

Original Paper

Experimental transmissibility of mutant SOD1 motor neuron disease

Original Paper

Zebrafish models of BAG3 myofibrillar myopathy suggest a toxic gain of function leading to BAG3 insufficiency

Commentary

PART and SNAP

Original Paper

Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

Original Paper

Aβ immunotherapy for Alzheimer’s disease: effects on apoE and cerebral vasculopathy

Erratum

Erratum to: Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice